ChromaDex Corp. Files Definitive Proxy Statement

TL;DR

<b>ChromaDex Corp. has filed its Definitive Proxy Statement for the 2023 fiscal year, detailing executive compensation and corporate governance matters.</b>

AI Summary

ChromaDex Corp. (NAGE) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. ChromaDex Corp. filed a Definitive Proxy Statement (DEF 14A) on April 25, 2024. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 10900 Wilshire Blvd, Suite 600, Los Angeles, CA 90024. ChromaDex Corp. was formerly known as CODY RESOURCES, INC. before a name change on January 12, 2007. The filing indicates no fee was required for this filing, or it was paid previously.

Why It Matters

For investors and stakeholders tracking ChromaDex Corp., this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation structures and potential changes, enabling informed voting decisions at upcoming meetings. The DEF 14A provides transparency into the company's governance, including details on equity awards and pension values, which can impact investor confidence and long-term strategy.

Risk Assessment

Risk Level: — ChromaDex Corp. shows moderate risk based on this filing. The filing is a routine DEF 14A, which typically contains standard disclosures about executive compensation and corporate governance, posing no immediate or unusual risk.

Analyst Insight

Shareholders should review the executive compensation details and any proposed resolutions to make informed voting decisions.

Key Numbers

• 2023-12-31 — Fiscal Year End (Reporting Period)
• 2024-04-25 — Filing Date (DEF 14A Filing)

Key Players & Entities

• ChromaDex Corp. (company) — Registrant
• 10900 Wilshire Blvd, Suite 600, Los Angeles, CA 90024 (location) — Business Address
• CODY RESOURCES, INC. (company) — Former Company Name
• 20070112 (date) — Date of Name Change

FAQ

Industry Context

ChromaDex Corp. operates in the medicinal chemicals and botanical products industry, focusing on health and wellness supplements.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

What Investors Should Do

1. Review the detailed executive compensation breakdown for 2023.
2. Understand the proposals to be voted on at the shareholder meeting.
3. Assess any changes in corporate governance practices outlined in the filing.

Key Dates

• 2024-04-25: Filing Date — Definitive Proxy Statement filed

Year-Over-Year Comparison

This is the company's definitive proxy statement for the 2023 fiscal year, filed on April 25, 2024.

Filing Documents

• cdxc-20240425.htm (DEF 14A) — 652KB
• cdxc-20240425_g1.jpg (GRAPHIC) — 5KB
• cdxc-20240425_g2.jpg (GRAPHIC) — 100KB
• cdxc-20240425_g3.jpg (GRAPHIC) — 87KB
• cdxc-20240425_g4.jpg (GRAPHIC) — 88KB
• cdxc-20240425_g5.jpg (GRAPHIC) — 181KB
• cdxc-20240425_g6.jpg (GRAPHIC) — 143KB
• 0001628280-24-018138.txt (&nbsp;) — 2739KB
• cdxc-20240425.xsd (EX-101.SCH) — 5KB
• cdxc-20240425_lab.xml (EX-101.LAB) — 10KB
• cdxc-20240425_pre.xml (EX-101.PRE) — 6KB
• cdxc-20240425_htm.xml (XML) — 98KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 38 OTHER MATTERS Householding of Proxy Materials 40 Other Business 40 -i- Table of Contents ChromaDex Corporation 10900 Wilshire Blvd, Suite 600 Los Angeles, CA 90024 PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS JUNE 20, 2024 INTRODUCTION The enclosed proxy is solicited by the Board of Directors ("Board of Directors" or "Board") of ChromaDex Corporation (the "Company"), in connection with the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of the Company, to be held on June 20, 2024, at 3:00 p.m. Pacific Time at the Company's office located at 10900 Wilshire Boulevard, Suite 600, Los Angeles, California 90024. At the Annual Meeting, you will be asked to consider and vote upon the following matters: (1) Election of eight director nominees named in this proxy statement (this "Proxy Statement"); (2) Ratification of selection of Marcum LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024; and (3) Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this Proxy Statement. We will also address other business that may properly come before the meeting and any postponement(s) or adjournment(s) thereof. The Board of Directors has fixed the close of business on April 22, 2024 as the record date (the "Record Date") for determining stockholders entitled to notice of and to vote at the Annual Meeting and any adjournment thereof. In accordance with rules and regulations adopted by the U.S. Securities and Exchange Commission (the "SEC"), we have elected to provide our beneficial owners and stockholders of record access to our proxy materials over the Internet. Beneficial owners are stockholders whose shares are held in the name of a broker, bank or other agent (i.e., in "street name"). Accordingly, a Notice of Internet Availability of Proxy Materials (the "Notice") will be

View Full Filing

View this DEF 14A filing on SEC EDGAR